Ma Bryan, James Matthew T, Javaheri Pantea A, Kruger Denise, Graham Michelle M, Har Bryan J, Tyrrell Benjamin D, Heavener Shane, Puzey Clare, Benterud Eleanor
Department of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, AB, Canada.
Can J Kidney Health Dis. 2023 Oct 18;10:20543581231206127. doi: 10.1177/20543581231206127. eCollection 2023.
Different models exist to guide successful implementation of electronic health tools into clinical practice. The Contrast Reducing Injury Sustained by Kidneys (Contrast RISK) initiative introduced an electronic decision support tool with physician audit and feedback into all of the cardiac catheterization facilities in Alberta, Canada, with the goal of preventing contrast-associated acute kidney injury (CA-AKI) following coronary angiography and intervention. This report describes the change management approaches used by the initiative and end-user's feedback on these processes.
The Canada Health Infoway Change Management model was used to address 6 activities relevant to project implementation: governance and leadership, stakeholder engagement, communications, workflow analysis and integration, training and education, and monitoring and evaluation. Health care providers and invasive cardiologists from all sites completed preimplementation, usability, and postimplementation surveys to assess integration and change success.
Prior to implementation, 67% of health providers were less than satisfied with processes to determine appropriate contrast dye volumes, 47% were less than satisfied with processes for administering adequate intravenous fluids, and 68% were less than satisfied with processes to ensure follow-up of high-risk patients. 48% of invasive cardiologists were less than satisfied with preprocedural identification of patients at risk of acute kidney injury (AKI). Following implementation, there were significant increases among health providers in the odds of satisfaction with processes for identifying those at high risk of AKI (odds ratio [OR] 3.01, 95% confidence interval [CI] 1.36-6.66, = .007), quantifying the appropriate level of contrast dye for each patient (OR 6.98, 95% CI 3.06-15.91, < .001), determining the optimal amount of IV fluid for each patient (OR 1.86, 95% CI 0.88-3.91, = .102), and following up of kidney function of high risk patients (OR 5.49, 95%CI 2.45-12.30, < .001). There were also significant increases among physicians in the odds of satisfaction with processes for identifying those at high risk of AKI (OR 19.53, 95% CI 3.21-118.76, = .001), quantifying the appropriate level of contrast dye for each patient (OR 26.35, 95% CI 4.28-162.27, < .001), and for following-up kidney function of high-risk patients (OR 7.72, 95% CI 1.62-36.84.30, = .010). Eighty-nine percent of staff perceived the initiative as being successful in changing clinical practices to reduce the risk of CA-AKI. Physicians uniformly agreed that the system was well-integrated into existing workflows, while 42% of health providers also agreed.
The Canada Health Infoway Change Management model was an effective framework for guiding implementation of an electronic decision support tool and audit and feedback intervention to improve processes for AKI prevention within cardiac catheterization units.
存在不同的模型来指导将电子健康工具成功应用于临床实践。减少肾脏造影剂损伤(Contrast RISK)倡议在加拿大艾伯塔省的所有心脏导管插入设施中引入了一种带有医生审核和反馈的电子决策支持工具,目标是预防冠状动脉造影和介入术后的造影剂相关性急性肾损伤(CA - AKI)。本报告描述了该倡议所采用的变革管理方法以及最终用户对这些流程的反馈。
加拿大健康信息高速公路变革管理模型用于处理与项目实施相关的6项活动:治理与领导、利益相关者参与、沟通、工作流程分析与整合、培训与教育以及监测与评估。来自所有站点的医疗保健提供者和介入心脏病专家完成了实施前、可用性和实施后调查,以评估整合情况和变革的成功程度。
在实施之前,67%的医疗保健提供者对确定合适造影剂用量的流程不满意,47%对给予充足静脉输液的流程不满意,68%对确保高危患者随访的流程不满意。48%的介入心脏病专家对术前识别急性肾损伤(AKI)风险患者不满意。实施后,医疗保健提供者对识别AKI高危患者流程的满意度几率显著增加(优势比[OR]3.01,95%置信区间[CI]1.36 - 6.66,P = 0.007),为每位患者量化合适的造影剂水平(OR 6.98,95%CI 3.06 - 15.91,P < 0.001),确定每位患者的最佳静脉输液量(OR 1.86,95%CI 0.88 - 3.91,P = 0.102),以及对高危患者肾功能进行随访(OR 5.49,95%CI 2.45 - 12.30,P < 0.001)。医生对识别AKI高危患者流程的满意度几率也显著增加(OR 19.53,95%CI 3.21 - 118.76,P = 0.001),为每位患者量化合适的造影剂水平(OR 26.35,95%CI 4.28 - 162.27,P < 0.001),以及对高危患者肾功能进行随访(OR 7.72,95%CI 1.62 - 36.84,P = 0.010)。89%的工作人员认为该倡议在改变临床实践以降低CA - AKI风险方面是成功的。医生一致认为该系统已很好地整合到现有工作流程中,42%的医疗保健提供者也表示同意。
加拿大健康信息高速公路变革管理模型是一个有效的框架,用于指导电子决策支持工具的实施以及审核和反馈干预,以改善心脏导管插入科室预防AKI的流程。